Home Infusion Therapy Market Is Expecting Revenue Growth To Reach $31.9 Billion By 2022: Grand View Research, Inc.

New Market Research Reports Title Global Home Infusion Therapy Market Analysis Size And Segment Forecasts To 2022 Has Been Added to GrandViewReseach.com Report Database.

Global home infusion therapy market is expected to reach USD 31.9 billion by 2022, according to a new study by Grand View Research Inc. Rising incidence of chronic disorders has led to an augmentation in the demand for infusion therapy in outpatient settings, thereby boosting the home infusion therapy market. Rapidly growing geriatric population base globally, is also likely to serve this market as a high impact rendering driver. The home infusion therapy is considered beneficial for patients as they get the entire treatment at the comfort of their home. Furthermore, home infusion therapy is a cost effective alternative to placement in hospital, and allows patients to adhere to their normal lifestyle while receiving treatment. Rising incidences of hospital acquired infections is a high impact rendering driver of this market. Additional healthcare spending associated with these infections are expected to encourage patients to prefer home care over the conventional settings.

Full research report on Global Home Infusion Therapy Market with detailed figures and charts available at:
http://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market

Image: http://www.abnewswire.com/uploads/eae1e11cb077bac1309e23b469b37f24.png

Global Home Infusion Therapy Market, by region, 2012 – 2022 (USD Billion)

Further key findings from the study suggest:

Needleless connectors are expected to witness lucrative growth over the forecast period. Growing demand for enhanced healthcare service provider safety has led to the rise in demand for needleless connectors.
Anti-Infective dominated the market with a revenue share of over 25.0% in 2014. Home administration of anti-infective therapy is preferred by patients who have chronic infections that cannot be treated through oral agents. It is considered as the most user friendly home infusion therapy.
North America accounted for more than 40% of the home infusion therapy market in 2014 on account of the presence of large geriatric population base. Presence of sophisticated healthcare infrastructure and favorable reimbursement plans laid out by regulatory bodies are also expected to make significant contributions towards market growth.
Asia Pacific is expected to emerge as a high growth market over the forecast period. Presence of large unmet needs in the emerging economies such as China and India. Rising patient awareness levels regarding the benefits of home infusion therapies over the in-hospital infusion therapies is expected to further boost the growth of this region.
Key players of home infusion therapy market include B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, CareFusion Corporation and Hospira Inc. Mergers and acquisitions and entering into strategic collaborations with healthcare providers are two key sustainability strategies adopted by these market participants.

Get more information on Global Home Infusion Therapy Market or request for sample of this research report at:
http://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market

For the purpose of this study, Grand View Research has segmented the global home infusion therapy market on the basis of products, application, and region:

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumption
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Home Infusion Therapy – Industry Summary and Key Buying Criteria, 2012 – 2022
Chapter 3. Home Infusion Therapy Industry Outlook
3.1. Home infusion therapy market segmentation
3.2. Home infusion therapy market size and growth prospects
3.3. Home infusion therapy market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry analysis – Porter’s
3.6. Home infusion therapy market PESTEL analysis, 2014
3.7. Home infusion therapy – Unmet need analysis
Chapter 4. Home Infusion Therapy Product Outlook
4.1. Home infusion therapy market share by product, 2014 & 2022
4.2. Infusion pumps
4.2.1. Infusion pumps market estimates and forecasts, 2012 – 2022 (USD Million)
4.3. Intravenous sets
4.3.1. Intravenous sets market estimates and forecasts, 2012 – 2022 (USD Million)
4.4. Needleless connectors
4.4.1. Needleless connectors market estimates and forecasts, 2012 – 2022 (USD Million)
Chapter 5. Home Infusion Therapy Application Outlook
5.1. Home infusion therapy market share by application, 2014 & 2022
5.2. Anti-infective
5.2.1. Anti-infective market estimates and forecasts, 2012 – 2022 (USD Million)
5.3. Hydration therapy
5.3.1. Hydration therapy market estimates and forecasts, 2012 – 2022 (USD Million)
5.4. Chemotherapy
5.4.1. Chemotherapy market estimates and forecasts, 2012 – 2022 (USD Million)
5.5. Enteral Nutrition
5.5.1. Enteral nutrition market estimates and forecasts, 2012 – 2022 (USD Million)
5.6. Parenteral nutrition
5.6.1. Parenteral nutrition market estimates and forecasts, 2012 – 2022 (USD Million)
5.7. Specialty pharmaceuticals
5.7.1. Specialty pharmaceuticals market estimates and forecasts, 2012 – 2022 (USD Million)
5.8. Others
5.8.1. Others market estimates and forecasts, 2012 – 2022 (USD Million)
Chapter 6. Home infusion therapy Regional Outlook
6.1. Home infusion therapy market share by region, 2014 & 2022
6.2. North America
6.2.1. North America home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.2.1.1. U.S. market estimates and forecasts
6.2.1.2. Canada market estimates and forecasts
6.2.2. North America home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)
6.2.2.1. U.S. market estimates and forecasts
6.2.2.2. Canada market estimates and forecasts
6.3. Europe
6.3.1. Europe home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.3.1.1. Germany market estimates and forecasts
6.3.1.2. UK market estimates and forecasts
6.3.2. Europe home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)
6.3.2.1. Germany market estimates and forecasts
6.3.2.2. UK market estimates and forecasts
6.4. Asia Pacific
6.4.1. Asia Pacific home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.4.1.1. China market estimates and forecasts
6.4.1.2. Japan market estimates and forecasts
6.4.2. Asia Pacific home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)
6.4.2.1. China market estimates and forecasts
6.4.2.2. Japan market estimates and forecasts
6.5. Latin America
6.5.1. Latin America home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.5.2. Latin America home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)
6.6. MEA
6.6.1. MEA home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.6.2. MEA home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)
Chapter 7. Competitive Landscape
7.1. Terumo Corporation
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. B. Braun Melsungen
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Caesarea Medical Electronics
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Smiths Medical
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. CareFusion Corporation
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. ICU Medical Inc.
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. JMS Co. Ltd.
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Baxter Inc.
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Fresenius Kabi
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information, visit: http://www.grandviewresearch.com/

Blog: http://www.dniamericas.org/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/05/1432643465.jpeg

“Grand View Research, Inc. – Market Research And Consulting.”

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Email: haakon@grandviewresearch.com
Phone: 1-415-349-0058
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market

Source: ABNewswire

ReleaseID: 28879

Go Top